Next-Generation Basophil Activation Test Launched
One-Sentence Summary:Beckman Coulter Life Sciences has launched a next-generation Basophil...
One-Sentence Summary:Beckman Coulter Life Sciences has launched a next-generation Basophil...
ALK introduced new FDA-approved AccuTest line of allergy skin testing devices and allergen well trays for allergy testing and diagnosis.
AMPEL BioSolutions' predictive AI-driven blood test for Lupus forecasts patient flares and drug targets from gene expression.
Quest and Scipher Medicine will collaborate to expand access to diagnostic services advancing precision medicine for rheumatoid arthritis.
Read MoreAqtual demonstrated its platform can identify synovial gene expression signatures in patients with rheumatoid arthritis using a blood test.Â
Read MoreMayo Clinic’s new collaboration will bring Progentec’s suite of biomarker blood tests for the management of autoimmune diseases to market.Â
Read MoreResearchers reported for the first time that a genetic biomarker may be able to help predict the severity of food allergy reactions.Â
Read MoreResearchers from the University of Houston are working to bring AI into the diagnostic picture for Lupus Nephritis.
Read MoreResearchers at the University of Basel and the University Hospital of Basel described a possible new MS-like disease and how to diagnose it.
Read MoreThe noninvasive method diagnoses atopic dermatitis by analyzing RNA from samples of sebum collected from infants using an oil-blotting film.
Read MoreProgentec launched a study with GSK aimed at identifying people at risk of developing lupus and guiding their virtual diagnostic journey.
Read MorePatients with antiphospholipid syndrome are given different medications to reduce their risk of blood clotting and help normalize lab values.
Read MoreResearchers from the University of Zurich (UZH) have now detected the Alongshan virus (ALSV) for the first time in ticks in Switzerland.
Read MoreAMPEL BioSolutions unveiled a genetic precision medicine test for lupus patients that could predict heart disease before it happens.
Read MoreThe number of new diagnoses of rheumatoid arthritis fell by 20% in the first year of the COVID-19 pandemic, new research suggests.
Read MoreT2 Biosystems plans to commercialize, a diagnostic test for early Lyme disease, with a goal of releasing it in the U.S. as an LDT in 2023.
Read MoreSebia has announced the acquisition of Zeus Scientific, an In Vitro Diagnostic (IVD) company based in New Jersey.
Read MoreA team of researchers are ramping up and reimagining how medical professionals diagnose tick-borne infections such as Lyme disease.  Â
Read More